N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study.
about
Characterization of human aspartoacylase: the brain enzyme responsible for Canavan diseaseHigh resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten diseaseActivation by N-Acetyl-l-Aspartate of Acutely Dissociated Hippocampal Neurons in Rats via Metabotropic Glutamate ReceptorsProton MRS in mild cognitive impairment.Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.Magnetic resonance spectroscopy in Alzheimer's disease.Magnetic resonance spectroscopy in common dementiasMagnetic resonance imaging and magnetic resonance spectroscopy in dementiasImaging of Alzheimer's disease.Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.pH optimization for a reliable quantification of brain tumor cell and tissue extracts with (1)H NMR: focus on choline-containing compounds and taurine.Sodium MR imaging detection of mild Alzheimer disease: preliminary studyDefective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan diseaseMagnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study.Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease.Quantitative computed tomography and magnetic resonance imaging in aging and Alzheimer's disease. A review.Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.1H MR spectroscopy in common dementias1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's diseaseApplications of high-resolution magic angle spinning MRS in biomedical studies I-cell line and animal models.In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study.Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.Effects of severe global ischemia on N-acetylaspartate and other metabolites in the rat brain.Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.Relation between 1H MR spectroscopic imaging and regional cerebral glucose metabolism in Alzheimer's disease.Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease.Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.N-acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging.Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software.Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.Proton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: a combination of techniques that may contribute to the diagnosis of Alzheimer's disease.
P2860
Q28237914-EA1A91E6-06B3-4E8B-9744-AA7EF7942A98Q28505711-9685BBFB-C9B5-4606-A8A7-7614D08B5ACEQ29999184-C463F919-2D58-487D-A26D-BADA35C87C4CQ30606675-858CDD64-4743-4518-9324-5FB24CCFB145Q30624704-75C38F4A-83AA-4396-9DC2-5B7AC3CF124DQ30630699-269A1F98-1C87-445F-BBC6-49C533AFD8F6Q30660402-66655E87-F713-49BF-A608-099CF2A94EFDQ30660816-24279681-45B1-40A0-A74F-FDEE1C7B5D76Q30815106-92EAC6BA-7E56-48F6-B9A7-7814535A5D75Q30983010-C2A747BF-8FD9-415E-BBB9-FBFD56200897Q30996805-85268962-416B-4F0D-A86C-868410807EF5Q31159878-0AEFD66C-A3E0-4533-ACF4-8E5865983AE6Q33744117-C6AF4E45-35D8-4885-9A00-AAFBC1569F64Q33836441-7D932A90-8DFB-4614-9E39-6F0350259C84Q33933163-CB9D65D7-1123-4C6F-9202-5A377CE4AC93Q34500635-6ADEC1D9-8F9E-4ABD-8F16-3B0B7E49B109Q35319467-9B790943-85E5-44F1-9444-E17A33A6A6D1Q36257224-E580A1C0-F6BA-4080-BF3B-54515953CFA9Q36790477-7D99039B-25A9-493B-BA76-E0BAE04E2ADCQ37322643-FABD6348-06E8-4B65-A038-F1F354FF8F02Q37358672-0CB4541B-46BB-4E9D-8175-F0163B8A8C1BQ37398605-76BE8AAD-4F5E-4754-930E-0B93624CD5D8Q37398623-1F799499-498A-44BF-A108-A6179D90E38BQ37407266-1A535BEB-AFB0-447E-B56D-1E8E5759F2C7Q37486254-9E5A23E7-E388-4CCC-99D7-AF89ABA79E6AQ38712030-8653CB09-FDF9-4753-A699-E88710889B14Q40978170-E2D9A3B7-A72E-4E71-A11E-1C8A8FAEE5D6Q41288398-A230D1F2-46D0-4A2E-A7E8-2DEE5EE49FF3Q41673623-F9B16843-D377-4106-9C0C-58DAE8137AABQ41693734-02C6E784-3609-44CF-9DD9-31E442DB03BEQ42096265-79A19CE4-9902-4343-B1B9-25C78D418E30Q42126269-7E16C3DA-2B31-4794-920D-586F3AC803C7Q43592164-6EE4B59F-9CDE-4953-A68A-601A5474212EQ44269590-49758D40-ECD6-4A12-8822-1E754972E1C0Q45292290-D2F894D0-ADEA-43AA-83D7-377FC6BEDA51Q45300316-E1BB84CD-DF80-4DBA-B0DA-7BAB9D3B3B7AQ46087310-F67B35FB-CC59-4255-8056-16C567D5748FQ46122831-C3B2E941-BCFF-40E1-B679-E3E27120D2FEQ46549871-C2DD9D41-05F0-48D4-A2E9-03E27423F8AEQ46601865-DB28B8CB-704D-4D4A-B2B9-DF435B22AFB2
P2860
N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
N-acetyl-L-aspartate and other ...... lear magnetic resonance study.
@en
type
label
N-acetyl-L-aspartate and other ...... lear magnetic resonance study.
@en
prefLabel
N-acetyl-L-aspartate and other ...... lear magnetic resonance study.
@en
P2093
P356
P1433
P1476
N-acetyl-L-aspartate and other ...... lear magnetic resonance study.
@en
P2093
McClure RJ
Panchalingam K
Pettegrew JW
P304
P356
10.1212/WNL.42.8.1578
P407
P577
1992-08-01T00:00:00Z